ArticleJournal for immunotherapy of cancer2022

CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment.

Mathieu Seyfrid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.